Top news
1.5 Million Pfizer Vaccine Doses, Donated by the United States, Arrive in Thailand
Why Hasn't The FDA Fully Approved Any Covid-19 Vaccines Yet?
By Katie Jennings
Citing New Data, Pfizer Outlines Case for Booster Shots (Published 2021)
By Apoorva Mandavilli, Sharon LaFraniere & Carl Zimmer
All coverage
Moderna says it plans to expand Covid vaccine trial for kids 5 to 11, will seek FDA OK as early as year-end
By Berkeley Lovelace & Berkeley Lovelace Jr.
Pfizer Revenue Boosted by Covid-19 Drugs
By Felix Richter
AstraZeneca Loses Money on Covid-19 Vaccine for Second Straight Quarter
By Cecilia Butini & Jenny Strasburg
Pfizer data suggest third dose of Covid-19 vaccine ‘strongly’ boosts protection against Delta variant
By Jacqueline Howard
FDA asks Pfizer, Moderna to test their vaccines in more children to help rule out safety issues
By Laurie McGinley, Carolyn Johnson & Yasmeen Abutaleb
EXCLUSIVE AstraZeneca exploring options for COVID-19 vaccine business - executive
By Pushkala Aripaka & Alistair Smout
Pfizer's CEO says Covid vaccine effectiveness drops to 84% after six months
By Kevin Stankiewicz
Vaccine Makers Are Asked to Expand Safety Studies on Children (Published 2021)
By Sharon LaFraniere, Sheryl Gay Stolberg & Noah Mercer Weiland
Pfizer and Moderna Are Expanding Vaccine Studies of Kids 5 to 11
By Sharon LaFraniere, Noah Mercer Weiland & Sheryl Gay Stolberg
Pfizer Expects $33.5 Billion In Vaccine Revenue In 2021
By Aayushi Pratap